Kingdon Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-257,650
Closed -$14.8M 78
2025
Q3
$14.8M Buy
257,650
+87,650
+52% +$5.05M 1.83% 16
2025
Q2
$10M Buy
170,000
+18,700
+12% +$1.21M 1.35% 31
2025
Q1
$11.1M Buy
+151,300
New +$12.5M 1.17% 22
2024
Q2
Sell
-190,900
Closed -$10.2M 93
2024
Q1
$10.2M Buy
+190,900
New +$10.3M 1.12% 39

Other funds holding GMED

Kingdon Capital Management's GMED Position: Q4 2025 in Review

Kingdon Capital Management sold out of Globus Medical (GMED) in Q4 2025, closing a stake of 257,650 shares — an estimated $14.8M sold.

Kingdon Capital Management first reported a position in GMED in Q1 2024 and held it in 4 quarters. The position peaked at $14.8M in Q3 2025. 563 funds tracked by Wall St. Rank hold GMED as of Q4 2025.

  • Kingdon Capital Management reported no remaining Globus Medical position as of Q4 2025 after selling out during the quarter.
  • Kingdon Capital Management sold 257,650 Globus Medical shares in Q4 2025, an estimated $14.8M.
  • Kingdon Capital Management first reported a position in Globus Medical in Q1 2024 and held it in 4 quarters.
  • Kingdon Capital Management's Globus Medical position peaked at $14.8M in Q3 2025.
  • 563 funds tracked by Wall St. Rank held Globus Medical as of Q4 2025.

Based on Kingdon Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.